Genomics-Driven Oncology: Framework for an Emerging Paradigm

被引:258
作者
Garraway, Levi A. [1 ,2 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Dana Farber Canc Inst, Sch Med, Boston, MA 02115 USA
[2] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA
关键词
SOMATIC MUTATIONS; INHIBITOR; 3-DEAZANEPLANOCIN; CHROMOSOMAL-ABNORMALITIES; FREQUENT MUTATIONS; MYELOID-LEUKEMIA; CELL CARCINOMA; CANCER; LANDSCAPE; GENES; ARID1A;
D O I
10.1200/JCO.2012.46.8934
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A majority of cancers are driven by genomic alterations that dysregulate key oncogenic pathways influencing cell growth and survival. However, the ability to harness tumor genetic information for its full clinical potential has only recently become manifest. Over the past several years, the convergence of discovery, technology, and therapeutic development has created an unparalleled opportunity to test the hypothesis that systematic knowledge of genomic information from individual tumors can improve clinical outcomes for many patients with cancer. Rigorous evaluation of this genomics-driven cancer medicine hypothesis will require many logistic innovations that are guided by overarching conceptual advances in tumor genomic profiling, data interpretation, clinical trial design, and the ethical return of genetic results to oncologists and their patients. The results of these efforts and the rigor with which they are implemented will determine whether and how comprehensive tumor genomic information may become incorporated into the routine care of patients with cancer.
引用
收藏
页码:1806 / 1814
页数:9
相关论文
共 76 条
[1]   Current systemic therapy for metastatic melanoma [J].
Agarwala, Sanjiv S. .
EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (05) :587-595
[2]   Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1 [J].
Agrawal, Nishant ;
Frederick, Mitchell J. ;
Pickering, Curtis R. ;
Bettegowda, Chetan ;
Chang, Kyle ;
Li, Ryan J. ;
Fakhry, Carole ;
Xie, Tong-Xin ;
Zhang, Jiexin ;
Wang, Jing ;
Zhang, Nianxiang ;
El-Naggar, Adel K. ;
Jasser, Samar A. ;
Weinstein, John N. ;
Trevino, Lisa ;
Drummond, Jennifer A. ;
Muzny, Donna M. ;
Wu, Yuanqing ;
Wood, Laura D. ;
Hruban, Ralph H. ;
Westra, William H. ;
Koch, Wayne M. ;
Califano, Joseph A. ;
Gibbs, Richard A. ;
Sidransky, David ;
Vogelstein, Bert ;
Velculescu, Victor E. ;
Papadopoulos, Nickolas ;
Wheeler, David A. ;
Kinzler, Kenneth W. ;
Myers, Jeffrey N. .
SCIENCE, 2011, 333 (6046) :1154-1157
[3]  
[Anonymous], 2012, EVOLUTION TRANSLATIO
[4]  
[Anonymous], 2011, PRECISION MED BUILDI
[5]  
[Anonymous], TARG CANC THER
[6]   Molecular Mechanisms Involved in the Synergistic Interaction of the EZH2 Inhibitor 3-Deazaneplanocin A with Gemcitabine in Pancreatic Cancer Cells [J].
Avan, Amir ;
Crea, Francesco ;
Paolicchi, Elisa ;
Funel, Niccola ;
Galvani, Elena ;
Marquez, Victor E. ;
Honeywell, Richard J. ;
Danesi, Romano ;
Peters, Godefridus J. ;
Giovannetti, Elisa .
MOLECULAR CANCER THERAPEUTICS, 2012, 11 (08) :1735-1746
[7]   Sequence analysis of mutations and translocations across breast cancer subtypes [J].
Banerji, Shantanu ;
Cibulskis, Kristian ;
Rangel-Escareno, Claudia ;
Brown, Kristin K. ;
Carter, Scott L. ;
Frederick, Abbie M. ;
Lawrence, Michael S. ;
Sivachenko, Andrey Y. ;
Sougnez, Carrie ;
Zou, Lihua ;
Cortes, Maria L. ;
Fernandez-Lopez, Juan C. ;
Peng, Shouyong ;
Ardlie, Kristin G. ;
Auclair, Daniel ;
Bautista-Pina, Veronica ;
Duke, Fujiko ;
Francis, Joshua ;
Jung, Joonil ;
Maffuz-Aziz, Antonio ;
Onofrio, Robert C. ;
Parkin, Melissa ;
Pho, Nam H. ;
Quintanar-Jurado, Valeria ;
Ramos, Alex H. ;
Rebollar-Vega, Rosa ;
Rodriguez-Cuevas, Sergio ;
Romero-Cordoba, Sandra L. ;
Schumacher, Steven E. ;
Stransky, Nicolas ;
Thompson, Kristin M. ;
Uribe-Figueroa, Laura ;
Baselga, Jose ;
Beroukhim, Rameen ;
Polyak, Kornelia ;
Sgroi, Dennis C. ;
Richardson, Andrea L. ;
Jimenez-Sanchez, Gerardo ;
Lander, Eric S. ;
Gabriel, Stacey B. ;
Garraway, Levi A. ;
Golub, Todd R. ;
Melendez-Zajgla, Jorge ;
Toker, Alex ;
Getz, Gad ;
Hidalgo-Miranda, Alfredo ;
Meyerson, Matthew .
NATURE, 2012, 486 (7403) :405-409
[8]   Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer [J].
Barbieri, Christopher E. ;
Baca, Sylvan C. ;
Lawrence, Michael S. ;
Demichelis, Francesca ;
Blattner, Mirjam ;
Theurillat, Jean-Philippe ;
White, Thomas A. ;
Stojanov, Petar ;
Van Allen, Eliezer ;
Stransky, Nicolas ;
Nickerson, Elizabeth ;
Chae, Sung-Suk ;
Boysen, Gunther ;
Auclair, Daniel ;
Onofrio, Robert C. ;
Park, Kyung ;
Kitabayashi, Naoki ;
MacDonald, Theresa Y. ;
Sheikh, Karen ;
Vuong, Terry ;
Guiducci, Candace ;
Cibulskis, Kristian ;
Sivachenko, Andrey ;
Carter, Scott L. ;
Saksena, Gordon ;
Voet, Douglas ;
Hussain, Wasay M. ;
Ramos, Alex H. ;
Winckler, Wendy ;
Redman, Michelle C. ;
Ardlie, Kristin ;
Tewari, Ashutosh K. ;
Mosquera, Juan Miguel ;
Rupp, Niels ;
Wild, Peter J. ;
Moch, Holger ;
Morrissey, Colm ;
Nelson, Peter S. ;
Kantoff, Philip W. ;
Gabriel, Stacey B. ;
Golub, Todd R. ;
Meyerson, Matthew ;
Lander, Eric S. ;
Getz, Gad ;
Rubin, Mark A. ;
Garraway, Levi A. .
NATURE GENETICS, 2012, 44 (06) :685-U107
[9]   Integrated genomic analyses of ovarian carcinoma [J].
Bell, D. ;
Berchuck, A. ;
Birrer, M. ;
Chien, J. ;
Cramer, D. W. ;
Dao, F. ;
Dhir, R. ;
DiSaia, P. ;
Gabra, H. ;
Glenn, P. ;
Godwin, A. K. ;
Gross, J. ;
Hartmann, L. ;
Huang, M. ;
Huntsman, D. G. ;
Iacocca, M. ;
Imielinski, M. ;
Kalloger, S. ;
Karlan, B. Y. ;
Levine, D. A. ;
Mills, G. B. ;
Morrison, C. ;
Mutch, D. ;
Olvera, N. ;
Orsulic, S. ;
Park, K. ;
Petrelli, N. ;
Rabeno, B. ;
Rader, J. S. ;
Sikic, B. I. ;
Smith-McCune, K. ;
Sood, A. K. ;
Bowtell, D. ;
Penny, R. ;
Testa, J. R. ;
Chang, K. ;
Dinh, H. H. ;
Drummond, J. A. ;
Fowler, G. ;
Gunaratne, P. ;
Hawes, A. C. ;
Kovar, C. L. ;
Lewis, L. R. ;
Morgan, M. B. ;
Newsham, I. F. ;
Santibanez, J. ;
Reid, J. G. ;
Trevino, L. R. ;
Wu, Y. -Q. ;
Wang, M. .
NATURE, 2011, 474 (7353) :609-615
[10]  
BLOOMFIELD CD, 1981, CANCER RES, V41, P4838